[1]
L. Pavlovskyi, “CERAMIDE AS A MARKER OF SEVERITY AND ACTIVITY OF DIABETES MELLITUS TYPE 2 AND NONALCOHOLIC FATTY LIVER DISEASE”, Biological Markers in Fundamental and Clinical Medicine (scientific journal), vol. 2, no. 2, pp. 68-68, Nov. 2018.